Saladax Biomedical CEO and leadership

Dr. Salamone has more than 30 years’ experience in the health care and medical device industries. Prior to founding Saladax in 2004, Dr. Salamone was Vice President of Research and Development at Roche Diagnostics where he was responsible for North American research and development efforts for the Laboratory Systems Division. During his 17-year tenure at Roche, Dr. Salamone’s efforts resulted in the launch of seven major reagent product lines, comprised of more than 70 FDA-approved products and more than 200 instrument applications. At Saladax Dr. Salamone’s group has developed proprietary positions in the field of oncology and psychiatry drug management. These assays address unmet medical needs in providing precision treatment. Dr. Salamone is recognized globally in the field of drug monitoring, having authored more than 100 publications, including articles, textbook chapters, books, and is also the holder of 41 issued US patents and the corresponding international patents. He has received numerous awards and in 2016 he was inducted into the prestige’s New Jersey Inventors Hall of Fame. Dr. Salamone earned two bachelor’s degrees from Villanova University, a master’s and a Ph.D degree from Rutgers University and was a Science Engineering Research Council (SERC) Post-Doctoral Fellow at Oxford University.

Adrienne Choma is a Board Member at Saladax Biomedical Inc and Senior VP/COO/Co-Founder at Saladax Biomedical Inc. She has worked as Chief Operating Officer at Alfa Wassermann, Attorney at Hoffmann-Laroche Inc, and VP:Mktg & Sales/Co-Founder at Saladax Biomedical Inc. Adrienne works or has worked as Vice President at Hoffmann-Laroche Inc. She attended New York University and Rutgers University.

Kevin Harter is a Board Member at Saladax Biomedical Inc, Co-Founder at Keystone Medical Systems, and President/CEO at Saladax Biomedical Inc. He has experience at Pennsylvania Blue Shield and has worked as Chairman at Saladax Biomedical Inc and Board Member at Legacy Bank. Kevin studied at Penn State University.

Dr. Salamone has more than 30 years’ experience in the health care and medical device industries. Prior to founding Saladax in 2004, Dr. Salamone was Vice President of Research and Development at Roche Diagnostics where he was responsible for North American research and development efforts for the Laboratory Systems Division. During his 17-year tenure at Roche, Dr. Salamone’s efforts resulted in the launch of seven major reagent product lines, comprised of more than 70 FDA-approved products and more than 200 instrument applications. At Saladax Dr. Salamone’s group has developed proprietary positions in the field of oncology and psychiatry drug management. These assays address unmet medical needs in providing precision treatment. Dr. Salamone is recognized globally in the field of drug monitoring, having authored more than 100 publications, including articles, textbook chapters, books, and is also the holder of 41 issued US patents and the corresponding international patents. He has received numerous awards and in 2016 he was inducted into the prestige’s New Jersey Inventors Hall of Fame. Dr. Salamone earned two bachelor’s degrees from Villanova University, a master’s and a Ph.D degree from Rutgers University and was a Science Engineering Research Council (SERC) Post-Doctoral Fellow at Oxford University.

Adrienne Choma is a Board Member at Saladax Biomedical Inc and Senior VP/COO/Co-Founder at Saladax Biomedical Inc. She has worked as Chief Operating Officer at Alfa Wassermann, Attorney at Hoffmann-Laroche Inc, and VP:Mktg & Sales/Co-Founder at Saladax Biomedical Inc. Adrienne works or has worked as Vice President at Hoffmann-Laroche Inc. She attended New York University and Rutgers University.

Dr. Salamone has more than 30 years’ experience in the health care and medical device industries. Prior to founding Saladax in 2004, Dr. Salamone was Vice President of Research and Development at Roche Diagnostics where he was responsible for North American research and development efforts for the Laboratory Systems Division. During his 17-year tenure at Roche, Dr. Salamone’s efforts resulted in the launch of seven major reagent product lines, comprised of more than 70 FDA-approved products and more than 200 instrument applications. At Saladax Dr. Salamone’s group has developed proprietary positions in the field of oncology and psychiatry drug management. These assays address unmet medical needs in providing precision treatment. Dr. Salamone is recognized globally in the field of drug monitoring, having authored more than 100 publications, including articles, textbook chapters, books, and is also the holder of 41 issued US patents and the corresponding international patents. He has received numerous awards and in 2016 he was inducted into the prestige’s New Jersey Inventors Hall of Fame. Dr. Salamone earned two bachelor’s degrees from Villanova University, a master’s and a Ph.D degree from Rutgers University and was a Science Engineering Research Council (SERC) Post-Doctoral Fellow at Oxford University.

Adrienne Choma is a Board Member at Saladax Biomedical Inc and Senior VP/COO/Co-Founder at Saladax Biomedical Inc. She has worked as Chief Operating Officer at Alfa Wassermann, Attorney at Hoffmann-Laroche Inc, and VP:Mktg & Sales/Co-Founder at Saladax Biomedical Inc. Adrienne works or has worked as Vice President at Hoffmann-Laroche Inc. She attended New York University and Rutgers University.

Kevin Harter is a Board Member at Saladax Biomedical Inc, Co-Founder at Keystone Medical Systems, and President/CEO at Saladax Biomedical Inc. He has experience at Pennsylvania Blue Shield and has worked as Chairman at Saladax Biomedical Inc and Board Member at Legacy Bank. Kevin studied at Penn State University.